ijms-logo

Journal Browser

Journal Browser

Phospholipids, Phosphosteroids and Sphingolipids in Metabolism and Health

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: closed (20 January 2023) | Viewed by 5100

Special Issue Editors


E-Mail Website
Guest Editor
Department of Analytical Chemistry, University of Granada, 18011 Granada, Spain
Interests: bioactive compounds; phytochemicals; human health; LC-MS; by-products; nutraceuticals; cosmeceuticals
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
IOMA, Belmont, CA, USA
Interests: spiral steroid phosphodiesters; NaK-ATPase; hypertension; sphingomyelin; endogenous potassium sparing diuretics

Special Issue Information

Dear Colleagues, 

For 40 years, phospholipids were a forgotten area of investigation. In the last five years, however, this has changed. This Special Issue aims to review the role of phosphodiesters in metabolism and health. We now know that sphingomyelins are important to our understanding of brain fog due to Alzheimer’s dementia or infection with HIV or SAR-COV-2. Steroid phospho-diesters have a key role in potassium regulation during pregnancy, essential hypertension, and PTSD. Both sphingosines and steroids can be attached to either phosphoethanolamine or phosphocholine diesters. However, both ethanolamine and choline are required nutrients, and the phosphoesters must be synthesized, in situ, perhaps from CDP-serine or phosphatidyl-serine. As the guest editor of this Special Issue, I welcome research papers, reviews, and novel concepts for the synthesis and metabolism of phospholipids and sphingolipids.

Dr. María De La Luz Cádiz-Gurrea
Dr. Chasalow Fred
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • spiral steroids
  • endogenous potassium sparing diuretics
  • sphingomyelin

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

14 pages, 2080 KiB  
Article
Phospholipid Scramblase 4 (PLSCR4) Regulates Adipocyte Differentiation via PIP3-Mediated AKT Activation
by Lisa A. G. Barth, Michèle Nebe, Hermann Kalwa, Akhil Velluva, Stephanie Kehr, Florentien Kolbig, Patricia Prabutzki, Wieland Kiess, Diana Le Duc, Antje Garten and Anna S. Kirstein
Int. J. Mol. Sci. 2022, 23(17), 9787; https://doi.org/10.3390/ijms23179787 - 29 Aug 2022
Cited by 4 | Viewed by 2931
Abstract
Phospholipid scramblase 4 (PLSCR4) is a member of a conserved enzyme family with high relevance for the remodeling of phospholipid distribution in the plasma membrane and the regulation of cellular signaling. While PLSCR1 and -3 are involved in the regulation of adipose-tissue expansion, [...] Read more.
Phospholipid scramblase 4 (PLSCR4) is a member of a conserved enzyme family with high relevance for the remodeling of phospholipid distribution in the plasma membrane and the regulation of cellular signaling. While PLSCR1 and -3 are involved in the regulation of adipose-tissue expansion, the role of PLSCR4 is so far unknown. PLSCR4 is significantly downregulated in an adipose-progenitor-cell model of deficiency for phosphatase and tensin homolog (PTEN). PTEN acts as a tumor suppressor and antagonist of the growth and survival signaling phosphoinositide 3-kinase (PI3K)/AKT cascade by dephosphorylating phosphatidylinositol-3,4,5-trisphosphate (PIP3). Patients with PTEN germline deletion frequently develop lipomas. The underlying mechanism for this aberrant adipose-tissue growth is incompletely understood. PLSCR4 is most highly expressed in human adipose tissue, compared with other phospholipid scramblases, suggesting a specific role of PLSCR4 in adipose-tissue biology. In cell and mouse models of lipid accumulation, we found PLSCR4 to be downregulated. We observed increased adipogenesis in PLSCR4-knockdown adipose progenitor cells, while PLSCR4 overexpression attenuated lipid accumulation. PLSCR4 knockdown was associated with increased PIP3 levels and the activation of AKT. Our results indicated that PLSCR4 is a regulator of PI3K/AKT signaling and adipogenesis and may play a role in PTEN-associated adipose-tissue overgrowth and lipoma formation. Full article
Show Figures

Figure 1

Review

Jump to: Research

22 pages, 5971 KiB  
Review
An Introduction to Spiral Steroids
by Fred Chasalow
Int. J. Mol. Sci. 2022, 23(17), 9523; https://doi.org/10.3390/ijms23179523 - 23 Aug 2022
Cited by 1 | Viewed by 1582
Abstract
In addition to classical steroids, which have cholesterol as a precursor, there are steroids with 7-dehydrocholesterol as a precursor. This review describes the identification of these steroids, their biosynthesis, and some aspects of their function. There are three classes of these compounds, distinguished [...] Read more.
In addition to classical steroids, which have cholesterol as a precursor, there are steroids with 7-dehydrocholesterol as a precursor. This review describes the identification of these steroids, their biosynthesis, and some aspects of their function. There are three classes of these compounds, distinguished by the number of their carbon atoms, 23, 24, and 25. Each class has a spiral steroid and is a phosphodiester. Up until these investigations, no spiral steroids or steroid phosphodiesters were known. There are at least 13 compounds, of which six have been purified to near homogeneity; each one has been characterized by its mass and proposed composition, and they function by regulating the NaK-ATPase. Based on the tissues in which they have been detected, each class of compound seems to regulate a different isoform of the NaK-ATPase. This is an important site of endocrine regulation. Full article
Show Figures

Figure 1

Back to TopTop